This is similar to our study where we found low-frequent Dsg3-specific B cells in PV patients (0.11–0.53% of CD19+ B cells) even though the acquired percentages can only be compared to a limited extent due to the different assays used. The gene discussed is CD19; the disease is acquired polycythemia vera.